---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-278858"
form_type: "8-K"
ticker: "OSRH"
cik: "0001840425"
company_name: "OSR Holdings, Inc."
filed_at: "2023-11-16T23:59:59+00:00"
generated_at: "2026-06-08T01:26:01.779272+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Bellevue Life Sciences SPAC to acquire OSR Holdings Co., Ltd. in share exchange

## Summary
- BLAC entered Business Combination Agreement to acquire at least 60% of OSR shares; minimum $5M+ cash in trust condition.
- Transaction requires BLAC stockholder approval, HSR clearance, and at least 60% of OSR holders to participate; outside date May 14, 2024.
- BLAC issued $180,000 unsecured promissory note to sponsor Bellevue Capital Management; due at closing or Dec 31, 2024.
- CEO Kuk Hyoun Hwang serves as CEO of both BLAC and OSR; M&A Committee of independent directors approved deal.
- BLAC adopted clawback policy to comply with Nasdaq listing standards under Section 10D of Exchange Act.

## SEC filing metadata
- accession: 0001193125-23-278858
- form_type: 8-K
- ticker: OSRH
- cik: 0001840425
- company_name: OSR Holdings, Inc.
- filed_at: 2023-11-16T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 2.03, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840425/000119312523278858/0001193125-23-278858-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840425/000119312523278858/d881994d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-278858
- JSON: https://secwatch.observer/filing/0001193125-23-278858.json
- Plain text: https://secwatch.observer/filing/0001193125-23-278858.txt

## Key facts
- Debt Financings
  OSR Holdings, Inc. incurred loan of $180,000 with Bellevue Capital Management LLC at not interest bearing maturing December 31, 2024 or the date on which BLAC consummates an initial business combination.
  - Instrument: loan
  - Principal: $180,000
  - Counterparty: Bellevue Capital Management LLC
  - Rate: not interest bearing
  - Maturity: December 31, 2024 or the date on which BLAC consummates an initial business combination
  - Event: incurrence
  source text: On November 13, 2023, BLAC issued an unsecured promissory note (the “ Promissory Note ”) in the principal amount of $180,000 to Bellevue Capital Management LLC, a Washington limited liability company and the Manager of Bellevue Global Life Sciences Investors, LLC, the Sponsor of BLAC (“BCM”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840425/000119312523278858/0001193125-23-278858-index.htm
- Material Agreements
  OSR Holdings, Inc. entered into Business Combination Agreement with Bellevue Life Sciences Acquisition Corp. (effective 2023-11-16).
  - Action: entry
  - Agreement: merger
  - Counterparty: Bellevue Life Sciences Acquisition Corp.
  - Effective: 2023-11-16
  source text: On November 16, 2023, Bellevue Life Sciences Acquisition Corp., a Delaware corporation (“ BLAC ”), and OSR Holdings Co., Ltd., a corporation organized under the laws of the Republic of Korea (the “ Company ”), entered into a Business Combination Agreement (the “ Business Combination Agreement ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840425/000119312523278858/0001193125-23-278858-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.